News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Direction For Drugmakers Such As Merck & Co., Inc. (MRK), Sanofi (France) (SAN.PA): Seeking Cure For Deadly Bowel Infection



4/14/2014 7:06:07 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Drugmakers led by Merck & Co. and Sanofi are searching for new weapons against a deadly bacteria behind hospital and nursing-home infections. Merck, Sanofi, Actelion Ltd. (ATLN) and Shire Plc (SHP) are among the companies vying to develop products to control or prevent Clostridium difficile, the bacteria most often implicated in infections found in medical facilities. The bug, linked to pain, fever, nausea and diarrhea, can add from $10,000 to $13,000 to a patient’s costs, according to a 2007 study.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES